Enveric Biosciences, Inc. (ENVB) Stock Forecast
ENVB analyst forecast
as of October 18, 2026- Analyst consensus
- —
- Price target
- $10.00 average of analyst targets
- Upside to target
- +624.6% from the latest close
- Next earnings
- November 13, 2026
- 52-week range
- $1.27 – $10.33
ENVB price target
The average of analyst 12-month price targets compared with the latest close and the 52-week range.
ENVB earnings per share estimates
| Period | Average | Low | High | Year ago | Growth | Analysts |
|---|---|---|---|---|---|---|
| Next fiscal year (2026) | $0.00 | $0.00 | $0.00 | — | — | — |
Consensus EPS estimates; growth compares the average estimate with the year-ago EPS.
ENVB revenue estimates
| Period | Average | Low | High | Growth | Analysts |
|---|---|---|---|---|---|
| Next fiscal year (2026) | $0 | $0 | $0 | — | — |
ENVB EPS: reported and forecast
Fiscal years; "E" marks estimates, the line shows the range from the lowest to the highest estimate.
ENVB EPS estimate revisions
| Period | 90 days ago | 60 days ago | 30 days ago | 7 days ago | Now | Change (90 d) | Revisions (30 d) |
|---|---|---|---|---|---|---|---|
| Next fiscal year (2026) | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | — | 1 up · 0 down |
How the consensus EPS estimate changed over the last 90 days, and how many analysts raised or lowered it in the last 30 days.
ENVB earnings surprises
Reported EPS vs the consensus estimate for the last 12 quarters; ENVB beat in 6 of 9.
What analysts expect from ENVB
The average price target is $10.00, 624.6% above the latest close of $1.38. For 2026 the average estimate is $0.00 per share. Enveric Biosciences beat the EPS estimate in 6 of the last 9 quarters.
Related: ENVB income statement, ENVB key metrics, ENVB chart. See the ENVB stock overview for the latest quote and news.
ENVB forecast FAQ
What is Enveric Biosciences's price target?
The average analyst price target for Enveric Biosciences is $10.00, 624.6% above the latest close of $1.38.
When does Enveric Biosciences report earnings?
Enveric Biosciences is expected to report results for the quarter ending September 30, 2026 on November 13, 2026.
Does Enveric Biosciences usually beat earnings estimates?
Enveric Biosciences reported EPS at or above the analyst estimate in 6 of the last 9 quarters.